Inducing Immune Infringement: The Interplay of § 287(c) and § 271(b)

by Libby Moulton
13 Colum. Sci. & Tech. L. Rev. 206 (Published Feb. 15, 2012)

Abstract

When the Physician’s Immunity Statute was enacted in 1997, its statutory language and legislative history left open an important question—under what circumstances should the medical practitioner’s immunity be extended to the inducer of an infringement?

This Article explores the relationship between the two patent statutes central to answering this question: the Physician’s Immunity Statute, 35 U.S.C. § 287(c), which grants immunity to medical practitioners who infringe a medical method patent, and the inducement statute, 35 U.S.C. § 271(b), which states that a patent holder may recover from a party who actively induces patent infringement. It concludes that there is indeed a conflict between the Physician’s Immunity Statute’s language and intent, especially when considered in conjunction with inducement statute’s policy of providing a useable remedy to infringement.

To resolve this conflict, the Article lays out a proposed framework for courts to determine when an inducer should be held liable for the infringement of a medical method patent. Courts should carefully interpret the language of section 287(c), and limit section 271(b) in some settings, in order to give proper effect to the policy that section 287(c) expresses.

About the Author

JD Candidate, Columbia Law School 2012.  MS, The George Washington University, 2009. BAS, University of Pennsylvania, 2006.  Law Clerk to Hon. Raymond C. Clevenger, United States Court of Appeals for the Federal Circuit, 2012-2013.

Important Note

For proper legal citation of this document, please cite to the following URL: http://www.stlr.org/cite.cgi?volume=13&article=5. The URL that currently appears in your browser’s location toolbar is incorrect. For more information on Bluebook citation of internet sources, click here.

View in PDF

Leave a Reply